Drug interaction between simvastatin and itraconazole in male and female rats

Drug Metabolism and Disposition

Volumn 29, Issue 7, 2001, Pages 1068-1072

  Ishigami, Michi ^a   Kawabata, Kiyoshi ^a   Takasaki, Wataru ^a   Ikeda, Toshihiko ^a   Komai, Toru ^a   Ito, Kiyomi ^b   Sugiyama, Yuichi ^c  

^a DAIICHI SANKYO CO   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG METABOLISM; FEMALE; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIFUNGAL AGENTS; AREA UNDER CURVE; DRUG INTERACTIONS; FEMALE; HUMANS; ITRACONAZOLE; MALE; MICROSOMES, LIVER; RATS; SIMVASTATIN;

ANIMALIA;

EID: 0034961288     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. In vivo effects of itraconazole on hepatic mixed function oxidase
2. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes
3. Interaction of cimetidine and ranitidine, the H2-receptor blockers, with mexazolam, a benzodiazepinooxazole- anxiolytic in rats
4. Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions
5. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport
6. Prediction of pharmacokinetic alterations caused by drug-drug interactions: Metabolic interaction in the liver
7. Sex difference of cytochrome P-450 in the rat: Purification, characterization, and quantification of constitutive forms of cytochrome P-450 from liver microsomes of male and female rats
8. Cytochrome P-450 as a determinant of sex difference of drug metabolism in the rat
9. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
10. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid
11. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole
12. Sex difference in metabolism of simvastatin by rat hepatic microsomes
13. Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole
14. In vitro metabolism of simvastatin in humans [SBT] identification of metabolizing enzymes and effect of the drug on hepatic P450s
15. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole
16. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG-CoA reductase
17. Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: Implication of concentrative uptake of inhibitors into liver